AUDDIA INC. 10-Q

Item 1. Financial Statements Auddia Inc. Condensed Balance Sheets June 30, 2026 December 31, 2025 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 9,558,190 $ 3,186,985 Accounts receivable, net 398 321 Prepaid assets 116,677 99,829 Other current assets 10,039 10,039 Total current assets 9,685,304 3,297,174 Non-current assets: Property and equipment, net of accumulated depreciation 4,865 6,670 Intangible assets, net of accumulated amortization 34,319 25,785 Software development costs, net of accumulated amortization 1,666,505 1,608,819 Operating lease right of use asset 28,457 44,392 Deferred offering costs 123,772 219,615 Total non-current assets 1,857,918 1,905,281 Total assets $ 11,543,222 $ 5,202,455 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued liabilities $ 818,427 $ 853,354 Notes payable – 60,520 Current portion of operating lease liability 35,426 38,612 Total current liabilities 853,853 952,486 Non-current operating lease liability – 14,475 Total liabilities 853,853 966,961 Commitments and contingencies (Note 5) – – Shareholders’ equity: Series C Preferred stock - $ 0.001 par value, 0 and 750 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively – 1 Common stock - $ 0.001 par value, 100,000,000 authorized and 5,803,182 and 402,833 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (1) 5,803 403 Additional paid-in capital 113,254,051 101,518,433 Accumulated deficit ( 102,570,485 ) ( 97,283,343 ) Total shareholders’ equity 10,689,369 4,235,494 Total liabilities and shareholders’ equity $ 11,543,222 $ 5,202,455 The accompanying notes are an integral part of these unaudited condensed financial statements. (1) The Company’s common stock outstanding as of June 30, 2026 and December 31, 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026. 4 Auddia Inc. Condensed Statements of Operations (Unaudited) Three Months Ended Six Months Ended June 30, June 30, 2026 2025 2026 2025 Revenue $ 7,584 $ – $ 7,584 $ – Operating expenses: Direct cost of services 65,947 58,566 121,111 114,136 Sales and marketing 456,965 185,157 907,411 420,598 Research and development 405,951 236,415 690,935 633,118 General and administrative 1,409,257 729,442 2,198,332 1,360,333 Restructuring 432,041 – 904,730 – Depreciation and amortization 261,401 357,628 497,497 790,035 Total operating expenses 3,031,562 1,567,208 5,320,016 3,318,220 Loss from operations ( 3,023,978 ) ( 1,567,208 ) ( 5,312,432 ) ( 3,318,220 ) Other expense: Interest income (expense) 48,712 ( 1,445 ) 55,613 ( 2,998 ) Total other income (expense) 48,712 ( 1,445 ) 55,613 ( 2,998 ) Loss before income taxes ( 2,975,266 ) ( 1,568,653 ) ( 5,256,819 ) ( 3,321,218 ) Provision for income taxes – – – – Net loss $ ( 2,975,266 ) $ ( 1,568,653 ) $ ( 5,256,819 ) $ ( 3,321,218 ) Net loss per share attributable to common stockholders Basic and diluted $ ( 0.71 ) $ ( 22.69 ) $ ( 2.26 ) $ ( 51.83 ) Weighted average common shares outstanding (1) Basic and diluted 4,178,649 69,132 2,323,380 64,084 The accompanying notes are an integral part of these unaudited condensed financial statements. (1) The Company’s weighted average common stock outstanding for the three and six months ended June 30 2026 and 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026. 5 Auddia Inc. Condensed Statements of Changes in Stockholders’ Equity for the Six Months Ended June 30, 2026 and 2025 (Unaudited) Series C Preferred Stock Common Stock (1) Additional Number of Shares Par Value Number of Shares Par Value Paid-In- Capital Accumulated Deficit Total Balance, December 31, 2025 750 $ 1 402,833 $ 403 $ 101,518,433 $ ( 97,283,343 ) $ 4,235,494 Issuance of common shares, net of costs of $ 27,592 – – 98,043 98 891,825 – 891,923 Offering costs – – – – ( 23,387 ) – ( 23,387 ) Share-based compensation – – – – 14,897 – 14,897 Capitalized dividends – – – – 30,323 ( 30,323 ) – RSS adjustment – – 38 – – – – Net loss – – – – – ( 2,281,553 ) ( 2,281,553 ) Balance, March 31, 2026 750 1 500,914 501 102,432,091 ( 99,595,219 ) 2,837,374 Issuance of common shares – – 1,405,006 1,405 2,180,317 – 2,181,722 Issuance of Pre-Funded Warrants – – – – 5,711,457 – 5,711,457 Common Warrant – – – – 4,106,814 – 4,106,814 Offering costs – – – – ( 1,190,179 ) – ( 1,190,179 ) Exercise of Pre-Funded Warrants into Common Stock – – 3,679,737 3,680 ( 3,680 ) – – Share-based compensation – – – – 15,087 – 15,087 Series C Preferred Conversion ( 750 ) ( 1 ) 191,815 192 ( 191 ) – – Exercise of Common Warrants – – 1,000 1 2,359 – 2,360 Conversion of Capitalized dividends into Common Shares – – 24,710 24 ( 24 ) – – Net loss – – – – – ( 2,975,266 ) ( 2,975,266 ) Balance, June 30, 2026 – $ – 5,803,182 $ 5,803 $ 113,254,051 $ ( 102,570,485 ) $ 10,689,369 Series C Preferred Stock Common Stock (1) Additional Number of Shares Par Value Number of Shares Par Value Paid-In- Capital Accumulated Deficit Total Balance, December 31, 2024 – $ – 51,653 $ 52 $ 94,122,702 $ ( 89,428,436 ) $ 4,694,320 Issuance of common shares, net of costs of $ 20,882 – – 10,253 10 672,785 – 672,795 Series B preferred stock converted to common stock – – 2,163 2 ( 139,012 ) – ( 139,010 ) Offering costs – – – – ( 55,120 ) – ( 55,120 ) Share-based compensation – – – – 76,906 – 76,906 Issuance of restricted stock units – – 25 – ( 0 ) – – Capitalized dividends converted to common stock – – 2,163 2 139,574 – 139,576 Capitalized dividends – – – – 58,758 ( 58,758 ) – Net loss – – – – – ( 1,752,565 ) ( 1,752,565 ) Balance, March 31, 2025 – – 66,257 66 94,876,593 ( 91,239,759 ) 3,636,902 Issuance of common shares, net of costs – – 3,247 3 82,497 82,500 Issuance of Series C preferred stock and warrants, net of issuance costs 750 1 – – 699,999 – 700,000 Series B preferred stock converted to common stock – – 15,552 16 ( 15 ) – – Share-based compensation – – – – 21,158 – 21,158 Capitalized dividends – – – – 44,350 ( 44,350 ) – RSS adjustment – – 4 – – – – Net loss – – – – – ( 1,568,653 ) ( 1,568,653 ) Balance, June 30, 2025 750 $ 1 85,060 $ 85 $ 95,724,582 $ ( 92,852,762 ) $ 2,871,907 The accompanying notes are an integral part of these unaudited condensed financial statements. (1) The Company’s common stock outstanding as of June 30, 2026 and 2025 and December 31, 2025 and 2024 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026. 6 Auddia Inc. Condensed Statements of Cash Flows (Unaudited) For the Six Months Ended June 30, 2026 2025 Cash flows from operating activities: Net loss $ ( 5,256,819 ) $ ( 3,321,218 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and amortization 497,497 790,035 Share-based compensation expense 29,984 98,064 Amortization of ROU asset 15,935 14,624 Change in assets and liabilities: Accounts receivable ( 77 ) ( 465 ) Prepaid assets ( 16,848 ) ( 49,523 ) Other current assets – – Accounts payable and accrued liabilities ( 34,927 ) ( 27,499 ) Lease liabilities ( 17,661 ) ( 12,667 ) Net cash used in operating activities ( 4,782,916 ) ( 2,508,649 ) Cash flows from investing activities: Software capitalization ( 551,857 ) ( 476,475 ) Intangibles capitalization ( 10,054 ) ( 14,175 ) Net cash used in investing activities ( 561,911 ) ( 490,650 ) Cash flows from financing activities: Offering costs ( 1,117,723 ) ( 95,125 ) Repayments of note payable ( 60,520 ) – Proceeds from issuance of preferred shares, net of issuance costs – 700,000 Proceeds from issuance of common shares 3,073,645 755,295 Proceeds from issuance of prefunded warrants 5,711,457 – Proceeds from issuance of common warrants 4,106,814 – Proceeds from exercise of common warrants 2,359 566 Net cash provided by financing activities 11,716,032 1,360,736 Net increase (decrease) in cash 6,371,205 ( 1,638,563 ) Cash, beginning of year 3,186,985 2,706,319 Cash and restricted cash, end of period $ 9,558,190 $ 1,067,756 Supplemental disclosures of cash flow information: Cash paid for interest $ 2,312 $ 2,997 Cash paid for taxes $ – $ – Supplemental disclosures of non-cash activity: Reclassification of deferred offering costs $ 95,843 $ 55,120 Capitalized dividends $ 30,323 $ 103,108 The accompanying notes are an integral part of these unaudited condensed financial statements. 7 Auddia Inc. Notes to Condensed Financial Statements (Unaudited) Note 1 – Description of Business, Basis of Presentation and Summary of Significant Accounting Policies Description of Business Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). Interim Financial Information The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2025 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature. Reverse Stock Splits On March 28, 2025, the Company effectuated a 1-for-17 reverse stock split . On March 31, 2026, the Company effectuated a 1-for-7.7 reverse stock split . The reverse stock splits did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock splits were rounded up to the nearest whole share. The reverse stock splits applied to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock splits. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans. 8 As a result of the reverse stock splits, unless described otherwise, all references to common stock, share data, per share data and related information contained in these financial statements have been retroactively adjusted to reflect the effect of the reverse stock splits for all periods presented. In addition, any fractional shares that would otherwise be issued as a result of the reverse stock splits were rounded up to the nearest whole share. Further, the number of shares issuable and exercise prices of stock options and warrants have been retrospectively adjusted in these financial statements for all periods presented to reflect the reverse stock splits. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed financial statements include some amounts that are based on management’s best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company’s common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant. Risks and Uncertainties The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks. Going Concern Our existing cash and cash equivalents was $ 9,558,190 at June 30, 2026 which will only be sufficient to fund our current operating plans into the second quarter of 2027. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. The Company has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company would be forced to delay, reduce, or eliminate our technology development and commercialization efforts. As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern. Cash and Cash Equivalents The Company had cash on hand of $ 411,270 and $ 1,052,990 as of June 30, 2026 and December 31, 2025, respectively. The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had cash equivalents of $ 9,146,920 and $ 2,133,995 as of June 30, 2026 and December 31, 2025, respectively. 9 The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of June 30, 2026, the Company had approximately $ 9.3 million in excess of federally insured limits. As of December 31, 2025, the Company had approximately $ 2.9 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests. Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives for owned assets, ranging from two to five years . Software Development Costs The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. Software development costs of $ 252,088 and $ 239,502 were capitalized for the three months ended June 30, 2026 and 2025, respectively. Software development costs of $ 551,857 and $ 476,475 were capitalized for the six months ended June 30, 2026 and 2025, respectively. Amortization of capitalized software development costs was $ 259,568 and $ 356,227 for the three months ended June 30, 2026 and 2025, respectively and $ 494,171 and $ 787,286 for the six months ended June 30, 2026 and 2025, respectively, and are included in depreciation and amortization expense in the Company’s condensed statement of operations. Long-Lived Assets The Company reviews its tangible and limited lived intangible long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. If a potential impairment is indicated, the Company compares the carrying amount of the asset to the undiscounted future cash flows associated with the asset. In the event the future cash flows are less than their carrying value, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The Company determined long-lived assets were no t impaired for the six months ended June 30, 2026 and 2025 and year ended December 31, 2025. Income Taxes The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized in the future. 10 The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense. Prior to the Company’s conversion to a Delaware corporation in February 2021, the Company was a limited liability company and had elected to be treated as a pass-through entity for income tax purposes. Accordingly, taxable income and losses of the Company were reported on the income tax returns of its members, and no provision for federal income taxes have been recorded in the accompanying financial statements. Had the Company been a taxable entity, no provision for income taxes would have been recorded as the Company has sustained losses since inception. Right of Use Assets and Lease Liabilities In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). The standard requires lessees to recognize almost all leases on the balance sheet as a Right-of-use (“ROU”) asset and a lease liability and requires leases to be classified as either an operating or a finance type lease. The standard became effective for the Company beginning January 1, 2019. The Company adopted ASC 842 using the modified retrospective approach, by applying the new standard to all leases existing at the date of initial application. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under ASC 842. Under ASC 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company’s lease does not provide an implicit rate, the Company estimated the incremental borrowing rate in determining the present value of lease payments. Operating leases are included in operating lease right of use asset and operating lease liabilities, current and non-current, on the Company’s accompanying balance sheets. Revenue Recognition Revenue is measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and is recognized based on consideration specified in a contract with a customer and excludes any sales incentives and amounts collected on behalf of third parties. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a service or product to a customer. To achieve this core principle, the Company applies the following five steps: ( 1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation. The Company reports revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the accompanying statements of operations. Collected taxes, if applicable, are recorded within other current liabilities until remitted to the relevant taxing authority. Subscriber revenue consists primarily of subscription fees and other ancillary subscription-based revenues. Revenue is recognized on a straight-line basis when the performance obligations to provide each service for the period have been satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions. Customers may pay for the services in advance of the performance obligation and therefore these prepayments are recorded as deferred revenue. The deferred revenue is recognized as revenue in the accompanying statements of operations as the services are provided. 11 Advertising Costs The Company expenses advertising costs as incurred. Advertising expense for the three months ended June 30, 2026 and 2025 was $ 232,106 and $ 53,143 , respectively. Advertising expense for the six months ended June 30, 2026 and 2025 was $ 417,009 and $ 143,238 , respectively. Share-Based Compensation The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant. Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods. Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with certain new or revised accounting standards that have different effective dates for public and private companies. We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (a) following the fifth anniversary of the completion of our IPO, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30th, and (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. Based on these criteria, the Company’s emerging growth company status is currently expected to expire on December 31, 2026 , unless it earlier meets one of the disqualifying conditions described above. 12 Note 2 – Property & Equipment, Intangible Assets, and Software Development Costs Property and equipment and software development costs consisted of the following as of: Schedule of property and equipment and software development costs June 30, 2026 December 31, 2025 Computers and equipment $ 102,125 $ 102,125 Furniture 11,258 11,258 Accumulated depreciation ( 108,518 ) ( 106,713 ) Total property and equipment, net $ 4,865 $ 6,670 Domain name $ 3,947 $ 3,947 Patents 33,781 23,596 Accumulated amortization ( 3,409 ) ( 1,758 ) Total intangible assets, net $ 34,319 $ 25,785 Software development costs $ 9,981,710 $ 9,429,985 Accumulated amortization ( 8,315,205 ) ( 7,821,166 ) Total software development costs, net $ 1,666,505 $ 1,608,819 The Company recognized depreciation expense of $ 903 and $ 1,348 for the three months ended June 30, 2026 and 2025, respectively, related to property and equipment, amortization expense of $ 930 and $ 163 for the three months ended June 30, 2026 and 2025, respectively, related to intangible assets, and amortization expense of $ 259,568 and $ 356,227 for the three months ended June 30, 2026 and 2025, respectively, related to software development costs. The Company recognized depreciation expense of $ 1,806 and $ 2,696 for the six months ended June 30, 2026 and 2025, respectively, related to property and equipment, amortization expense of $ 1,520 and $ 185 for the six months ended June 30, 2026 and 2025, respectively, related to intangible assets, and amortization expense of $ 494,171 and $ 787,286 for the six months ended June 30, 2026 and 2025, respectively, related to software development costs. Note 3 – Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of the following: Schedule of accounts payable and accrued liabilities June 30, 2026 December 31, 2025 Accounts payable $ 573,908 $ 577,774 Accrued liabilities 244,229 275,580 Credit cards payable 290 – $ 818,427 $ 853,354 13 Note 4 – Notes Payable On June 20, 2025, the Company entered into a promissory note to finance its directors and officers (“D&O”) insurance premium. The original principal amount of the note was $ 151,300 and bore interest at a fixed annual rate of 8.250 %. The note required monthly payments of principal and interest and matured on May 20, 2026 . The note has been fully paid down. As of June 30, 2026 and December 31, 2025, the outstanding principal balance was $ 0 and $ 60,520 , respectively. The note was unsecured and contained no financial covenants. Note 5 – Commitments and Contingencies Operating Lease On March 25, 2024, the Company entered into a 37-month operating lease commencing on April 1, 2024 with two separate two year renewal options. The monthly base rent for months two through 14 is $2,456, increasing to $3,070 for months 15 through 26, and ending at $3,684 for months 27 through 37. Rent expense, as part of general and administrative expenses in the statements of operations, was $ 21,199 and $ 8,960 for the three months ended June 30, 2026 and 2025, respectively and $ 42,183 and $ 17,920 for the six months ended June 30, 2026 and 2025, respectively. Litigation In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alle ged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable nor reasonably estimable as of the date the financial statements were issued, therefore, no accrual has been made. In addition, one investor in our April 2026 common stock and warrant public offering has contacted the Company claiming that it would be owed a cash payment for warrants it holds if the Company's proposed merger with Thramann Holdings LLC is consummated. We believe this investor's claim is without merit because all warrants expire in accordance with their terms prior to the consummation of the Company's pending merger. No complaint has been filed by this investor. If a complaint is filed, the Company believes it would have meritorious defenses to this claim and would intend to defend such case vigorously. The outcome of the claim was neither probable or estimable as of the date that these financial statements were issued. Therefore, no accrual has been made. Note 6 – Share-based Issuances Stock Options The fair value of each option award is estimated on the date of grant using a Black Scholes option valuation model that uses the assumptions noted in the following table. Because Black Scholes option valuation models incorporate ranges of assumptions for inputs, these ranges are disclosed. Expected volatilities and based on implied volatilities from traded options on the Company’s stock, historical volatility of the Company’s stock, and other factors. The expected term of options granted is derived from the output of the valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. 14 The following table presents the activity for stock options outstanding: Schedule of stock option activity Options Weighted Average Exercise Price Outstanding - December 31, 2025 17,640 $ 79.66 Granted – – Forfeited/canceled – – Exercised – – Outstanding – June 30, 2026 17,640 $ 79.66 Options Weighted Average Exercise Price Outstanding - December 31, 2024 4,460 $ 953.88 Granted – – Forfeited/canceled – – Exercised – – Outstanding – June 30, 2025 4,460 $ 953.88 The following table presents the composition of options outstanding and exercisable: Schedule of options outstanding and exercisable Options Outstanding** Options Exercisable** Exercise Prices Number Price Life* Number Price* $14.94 13,564 $ 14.94 9.45 5,203 $ 14.94 $66.75 3,821 $ 66.75 8.76 3,821 $ 66.75 $818.13 144 $ 818.13 7.71 71 $ 818.13 $1,295.91 16 $ 1,295.91 7.19 12 $ 1,295.91 $5,857.78 43 $ 5,857.78 5.88 43 $ 5,857.78 $9,130.28 20 $ 9,130.28 5.37 20 $ 9,130.28 $9,475.72 16 $ 9,475.72 1.84 16 $ 9,475.72 $13,927.65 16 $ 13,927.65 3.38 16 $ 13,927.65 Total - June 30, 2026 17,640 9,202 * Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively. ** The Company’s common stock outstanding as of June 30, 2026 and December 31, 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026. 15 Restricted Stock Units The following table presents the activity for restricted stock units outstanding: Schedule of restricted stock units outstanding Restricted Stock Units Weighted Average Grant Date Fair Value Outstanding - December 31, 2024 40 $ 7,398.47 Granted – – Forfeited/canceled 4 – Exercised ( 44 ) 7,398.47 Outstanding – June 30, 2025 – $ – The Company recognized share-based compensation expense related to stock options and restricted stock units of $ 15,087 and $ 21,158 for the three months ended June 30, 2026 and 2025, respectively and $ 29,984 and $ 98,064 for the six months ended June 30, 2026 and 2025. The remaining unvested share-based compensation expense of $ 140,678 is expected to be recognized over the next 39 months. Note 7 – Equity Financings Equity Line Common Stock Purchase Agreement On November 25, 2024, the Company entered into a new equity line Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time, up to $ 10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. On July 30, 2025, the Company amended the equity line Common Stock Purchase Agreement from $ 10,000,000 to $ 50,000,000 and extended the commitment to December 31, 2027. During the year ended December 31, 2025, the Company issued 129,221 shares of Common stock under the Equity Line Common Stock Purchase Agreement for total proceeds of $ 3.7 million. At-the-Market Sales Agreement The Company has entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”) with Ascendiant Capital Markets, LLC, as sales agent (the “Agent”). Under the Sales Agreement, the Company may sell shares of its common stock having an aggregate offering price of up to $ 10,000,000 from time to time, through an “at the market offering” (the “ATM Offering”). The aggregate market value of shares that the Company can sell under the Sales Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. During the three and six months ended June 30, 2026, the Company sold 0 and 98,043 shares, respectively under the Sales Agreement for proceeds of $ 0.9 million and currently has $ 0.0 million of unsold availability under the ATM facility. 16 During the year ended December 31, 2025, the Company issued 130,879 shares under the Sales Agreement for aggregate proceeds of approximately $ 2.8 million. $2.3 Million Convertible Series B Preferred Stock and Warrants Financing On April 23, 2024, the Company entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $ 2,314,000 of gross proceeds in connection with the closing of this financing. At the closing, the Company issued 2,314 shares of Series B convertible preferred stock (“Series B Preferred Stock”) at a purchase price of $ 1,000 per share of Series B Preferred Stock. The Series B Preferred Stock is convertible into Common Stock at an initial conversion price (“Conversion Price”) of $ 242.32 per share of Common Stock. The Company also issued warrants (“Warrants”) exercisable for 9,552 shares of Common Stock with a five-year term and an initial exercise price of $ 242.32 per share, which has been subsequently adjusted to $ 2.36 . The proceeds of this financing, together with other available cash resources, were used to repay outstanding debt and for general corporate purposes. Holders of the Series B Preferred Stock will be entitled to dividends in the amount of 10% per annum, payable quarterly. The Company has the option to pay dividends on the Series B Preferred Stock in additional shares of Common Stock. The Company also has the option to cumulate or “capitalize” the dividends, in which case the accrued dividend amount shall be added to the stated value of each share of Series B Preferred Stock. On February 19, 2025, 140 shares of Series B Preferred stock and capitalized dividends were converted to 4,326 shares of Common Stock. In April 2025, 447 shares of Series B Preferred stock and capitalized dividends were converted to 11,069 shares of Common stock. On June 26, 2025, 192 shares of Series B Preferred stock and capitalized dividends were converted to 4,484 shares of Common Stock. On August 5, 2025, the Company entered into a series of exchange agreements (the “Exchange Agreements”) with certain accredited investors to exchange 569 outstanding shares of the Company’s Series B preferred stock (including accrued dividends thereon) for 17,237 shares of common stock at an exchange price of $20.41 per common share. The issuance of the exchange common shares is intended to be exempt from registration pursuant to the exemptions under Section 3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”). As of June 30, 2026, no shares of Series B Preferred stock remain outstanding. $750,000 Series C Preferred Stock and Warrants Financing On June 30, 2025, the Company entered into a Securities Purchase Agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $ 750,000 of gross proceeds in connection with the closing of this financing. At the closing, the Company issued 750 shares of Series C convertible preferred stock (“Series C Preferred Stock”) at a purchase price of $1,000 per share of Series C Preferred Stock. The Series C Preferred Stock is convertible into Common Stock at an initial conversion price (“Series C Conversion Price”) of $36.73 per share of Common Stock. The Company also issued warrants exercisable for 40,841 shares of Common Stock with a five year term and an initial exercise price of $36.73 per share, which has been subsequently adjusted to $2.36. On April 23, 2026, the Company entered into an exchange agreement (the “Exchange Agreement”) with the accredited investors to exchange 750 outstanding shares of the Company’s Series C preferred stock plus capitalized dividends to date for 216,525 shares of common stock at an exchange price of $3.91 per common share. No shares of Series C preferred stock remain outstanding. 17 As of June 30, 2026, no shares of Series C Preferred stock remain outstanding. The proceeds of this financing, together with other available cash resources, will be used for general corporate purposes. April 2026 Registered Direct Offering On April 27, 2026, the Company closed a best-efforts registered direct offering (the “Offering”) of 1,405,006 shares of common stock, together with, in lieu of common stock for certain investors, 3,679,737 pre-funded warrants to purchase common stock (the “Pre-Funded Warrants”), and accompanying common stock purchase warrants to purchase up to 5,084,743 shares of common stock (the “Common Warrants”). The combined public offering price was $ 2.36 per share (or per Pre-Funded Warrant) and accompanying Common Warrant. Gross proceeds were $ 11,999,993 (approximately $12.0 million), before deduction of a 7.0 % cash fee payable to the placement agent and other offering expenses, together totaling approximately $ 1.2 million. Gross proceeds were allocated among the common stock, pre-funded warrants and common warrants on a relative fair value basis. The Pre-Funded Warrants have an exercise price of $ 0.001 per share, which was pre-funded at closing, and no stated expiration date; they remain exercisable until exercised in full. The Common Warrants have an exercise price of $ 2.36 per share and expire earlier of (i) five years from the initial exercise date and (ii) the consummation of the Company’s pending merger with Thramann Holdings, LLC (the "Merger"). All 3,679,737 Pre-Funded Warrants were exercised by April 30, 2026 for an aggregate exercise price of $3,680. As of June 30, 2026, 1,000 common warrants were exercised at $ 2.36 with the proceeds of $ 2,360 , leaving 5,083,743 Common Warrants outstanding. The Company evaluated the Common Warrants and Pre-Funded Warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity , and determined that both instruments are indexed to the Company’s own stock and meet the criteria for equity classification. Accordingly, the warrants have been classified within stockholders’ equity and are not subject to fair value remeasurement in future periods. All 3,679,737 Pre-Funded Warrants were exercised in full as of June 30, 2026. Upon exercise, $ 5,711,457 was reclassified from the Pre-Funded Warrants equity account to common stock and additional paid-in capital. No Pre-Funded Warrants remain outstanding. Warrant Valuation The Company estimated the fair value of the Common Warrants issued in the Offering on the issuance date using the Black-Scholes option-pricing model. The fair value of the Pre-Funded Warrants approximated their intrinsic value due to the nominal exercise price of $0.001 per share and was recorded within stockholders' equity. The assumptions used in estimating the fair value of the Common Warrants were based on information available at the issuance date. Because the Common Warrants and Pre-Funded Warrants met the criteria for equity classification under ASC 815-40, the warrants were recorded in stockholders' equity and are not subsequently remeasured. Schedule of assumptions Assumption Common Warrants Valuation methodology Black-Scholes option-pricing model Stock price $ 1.50 Exercise price $ 2.36 Risk-free rate 3.71 % Volatility 150 % Expected term (in years) 1.28 Dividend yield 0.00 % The expected term reflects management's estimate of the period until exercise or termination, including consideration of the pending merger transaction and the contractual provision causing the warrants to expire upon consummation of the merger. 18 Warrants The following table presents the activity for warrants outstanding: Schedule of activity for warrants outstanding Warrants Weighted Average Exercise Price Outstanding - December 31, 2025 54,699 $ 9.10 Granted 8,764,480 2.36 Forfeited/canceled – – Exercised ( 3,680,737 ) 2.36 Outstanding – June 30, 2026 5,138,442 $ 2.36 Warrants Weighted Average Exercise Price Outstanding - December 31, 2024 18,560 $ 980.29 Granted 40,840 36.73 Forfeited/canceled – – Exercised – – Outstanding – June 30, 2025 59,400 $ 331.56 During the six months ended June 30, 2026 and year ended December 31, 2025, in connection with the Series C Preferred Stock Issuance, the Company issued 0 and 40,840 , respectively warrants to purchase shares of common stock at the exercise price of $36.73. The per share exercise price has been adjusted to $2.36. Note 8 – Leases under ASC 842 The Company leases certain office space under operating leases for use in operations. The Company recognizes operating lease expense on a straight-line basis over the lease term. Management determines if an arrangement is a lease at contract inception. Lease and non-lease components are accounted for as a single component for all leases. Operating lease right to use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the expected lease term, which includes optional renewal periods if the Company determines it is reasonably certain that the option will be exercised. As the operating lease does not provide an implicit rate, the discount rate used in the present value calculation represents the incremental borrowing rate determined using information available at the commencement date. Rent expense, as part of general and administrative expenses in the statements of operations, was $ 21,199 and $ 8,960 for the three months ended June 30, 2026 and 2025, respectively and $ 42,183 and $ 17,920 for the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, weighted-average remaining lease term and discount rate were as follows: Schedule of weighted-average remaining lease term and discount rate June 30, 2026 Weighted-average remaining lease term 0.75 year Weighted-average discount rate 8.6 % 19 The following is a maturity analysis of the annual undiscounted cash flows reconciled to the carrying value of the operating lease liabilities as of June 30, 2026: Schedule of annual undiscounted cash flows of leases Years Ended December 31, 2026 $ 22,103 2027 14,735 Less imputed interest ( 1,412 ) Total $ 35,426 Note 9 – Segment Reporting Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the Chief Operating Decision Maker (“CODM”) in making decisions regarding resource allocation and assessing performance. The Company views its operations and manages its business in one operating segment engaged in the technology of how customers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company’s Chief Financial Officer (“CFO”), as the CODM, regularly reviews the entity-wide financial and operational performance as a single unit. No financial information is disaggregated into separate lines of businesses. The CFO makes resource allocation and business process decisions regarding the overall level of resources available and how to best deploy these resources. The single segment’s principal measure of segment profit and loss is consolidated research and development expenses and administrative expenses. The CFO considers actual and forecasted expenses when evaluating performance. Note 10 – Net Loss Per Share Basic net loss per share is computed by dividing net loss, which is allocated based upon the proportionate amount of weighted average shares outstanding, to each class of stockholder’s stock outstanding during the period. For the calculation of diluted net loss per share, net loss per share attributable to common stockholders for basic net loss per share is adjusted by the effect of dilutive securities, including awards under our equity compensation plans. For the three months ended of June 30, 2026 and June 30, 2025, 9,262,392 and 109,946 , respectively of potentially dilutive weighted average shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented. For the six months ended of June 30, 2026 and June 30, 2025 , 7,479 and 127,944 , respectively of potentially dilutive weighted average shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented. The shares underlying the Pre-Funded Warrants are included in basic weighted-average shares outstanding from the April 27, 2026 issuance date because the Pre-Funded Warrants are exercisable for nominal consideration and are not subject to any contingency other than the passage of time. The Common Warrants are excluded from basic earnings per share and are evaluated each period for their dilutive effect using the treasury stock method (or a method that reflects the Common Warrant’s cash-settlement feature); given the Company’s net losses, the Common Warrants were antidilutive and excluded from diluted earnings per share for the periods presented. 20 Note 11 – Subsequent Events Interim Bridge Funding for Target Companies On July 17, 2026, Auddia entered into a senior unsecured bridge note (each a “Bridge Note”) with each of Thramann Holdings, LT350, Influence, and Voyex. The purpose of the Bridge Notes is to provide a limited amount of interim funding and working capital to the Target Companies while the Merger Agreement is still pending. The Bridge Notes were reviewed and approved by a Auddia’s special committee of independent and disinterested directors (the “Special Committee”) and Audit Committee. Terms of the Bridge Notes Amount and Funding The maximum amount to be funded by Auddia under each of the Bridge Notes is up to (i) $360,000 for Thramann Holdings, (ii) $400,000 for LT350; (iii) $590,000 for Influence Healthcare; and (iv) $50,000 for Voyex. Amounts will be funded in tranches as mutually agreed to by the parties. Any advance in excess of $50,000 will require approval of the Auddia’s Audit Committee. No further amounts will be funded if the pending Merger Agreement is terminated. As of the date of this filing, the aggregate funded amount was $920,728. Interest Rate; Maturity Date Interest shall accrue at the rate of 8.0% per annum, compounded annually. Unless earlier repaid or converted, outstanding principal and unpaid accrued interest on each Bridge Note shall be due and payable upon the earlier of (i) the second anniversary of the termination of the Merger Agreement or (ii) a change of control (as defined in the Bridge Notes) involving a particular Target Company. In the event of a change of control involving LT350, Influence or Voyex, the particular Target Company would owe a repayment premium equal to 50% of the outstanding principal amount of its Bridge Note. Seniority and Security The Bridge Notes are unsecured senior obligations of each Target Company. Each Target Company has agreed not to incur any debt that would be secured or senior to its Bridge Note. Conversion Terms The Thramann Holdings Bridge Note is not convertible. If any of the other Target Companies consummates, on or prior to its Bridge Note maturity date, an equity financing pursuant to which it sells shares of its equity securities (the “Next Round Securities”), with an aggregate sales price of not less than the amount set forth below, excluding any and all indebtedness under the Bridge Note that is converted into Next Round Securities, and with the principal purpose of raising capital (a “Qualified Financing”), then all principal, together with all unpaid accrued interest under the particular Bridge Note, shall automatically convert into shares of the Next Round Securities at 80% of the cash price per share paid by the other purchasers of Next Round Securities in the Qualified Financing. The Qualified Financing threshold shall be (i) $3,000,000 for LT350; (ii) $2,000,000 for Influence; and $1,000,000 for Voyex. Credit of Funds for Cash Merger Closing Condition The Merger Agreement contains a closing condition that Auddia’s net cash at closing be at least equal to $12,000,000. The parties have agreed that any funds advanced by Auddia to the Target Companies under the Bridge Notes shall be credited to Auddia’s net cash at closing for purposes of this closing condition under the Merger Agreement. The above summary of the Bridge Notes does not purport to be a complete summary of the Bridge Notes and is qualified in its entirety by reference to the full text of each of the Bridge Notes, copies of which are filed herewith as an exhibit and are incorporated by reference. 21